Also, the study of Vansteenkiste et al. targeted Melanoma antigen family A (MAGE-A3), a prototype antigen that is a member of the MAGE-A family of antigens, in lung carcinoma, which did not increase disease free survival compared with placebo [35]. The gene discussed is MAGEA3; the disease is lung carcinoma.